Prospective studies reveal pruritus and its correlation with fatigue and rash in melanoma patients, suggesting systemic impacts of ICI therapy.
Pruritus is a common side effect of ICI therapy. Its correlation with irFatigue and irRash highlights the broader systemic impact impairing patients' quality of life. Further prospective studies are needed to elucidate the underlying mechanisms such as involvement of eosinophils and identify optimal treatment strategies while maintaining ICI effectiveness.
No takes yet. Share an insight, caveat, or question.
Roggo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: